Ligand Pharmaceuticals
LGND
#3601
Rank
ยฃ2.72 B
Marketcap
ยฃ138.67
Share price
-1.93%
Change (1 day)
41.63%
Change (1 year)

Revenue for Ligand Pharmaceuticals (LGND)

Revenue in 2025 (TTM): ยฃ0.18 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.18 Billion. In 2024 the company made a revenue of ยฃ0.13 Billion an increase over the revenue in the year 2023 that were of ยฃ0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ligand Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.18 B42.49%
2024 ยฃ0.13 B29.21%
2023 ยฃ0.10 B-27.88%
2022 ยฃ0.14 B-30.39%
2021 ยฃ0.20 B50.12%
2020 ยฃ0.13 B49.1%
2019 ยฃ91.72 M-53.7%
2018 ยฃ0.19 B89.74%
2017 ยฃ0.10 B18.21%
2016 ยฃ88.31 M81.99%
2015 ยฃ48.52 M17.07%
2014 ยฃ41.45 M39.62%
2013 ยฃ29.68 M52.88%
2012 ยฃ19.41 M0.49%
2011 ยฃ19.32 M26.74%
2010 ยฃ15.24 M-36.64%
2009 ยฃ24.06 M29.12%
2008 ยฃ18.63 M187.15%
2007 ยฃ6.49 M-83.01%
2006 ยฃ38.19 M-59.8%
2005 ยฃ95.01 M15.04%
2004 ยฃ82.59 M4.68%
2003 ยฃ78.9 M30.91%
2002 ยฃ60.27 M14.47%
2001 ยฃ52.65 M61.11%
2000 ยฃ32.68 M29.22%
1999 ยฃ25.29 M137.59%
1998 ยฃ10.64 M-66.18%
1997 ยฃ31.47 M45.65%
1996 ยฃ21.6 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
ยฃ26.98 B 14,217.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
ยฃ19.29 M-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.76 B 16,757.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ48.18 B 25,467.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.09 B 24,891.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ44.56 B 23,551.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.02 B 19,019.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
ยฃ8.26 B 4,287.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 36,578.70%๐Ÿ‡บ๐Ÿ‡ธ USA